现代医药卫生2024,Vol.40Issue(2) :288-292.DOI:10.3969/j.issn.1009-5519.2024.02.024

肺动脉高压相关病理机制的研究进展

Research progress on pathological mechanisms related to pulmonary arterial hypertension

刘思言 崔狄宇 陈运清
现代医药卫生2024,Vol.40Issue(2) :288-292.DOI:10.3969/j.issn.1009-5519.2024.02.024

肺动脉高压相关病理机制的研究进展

Research progress on pathological mechanisms related to pulmonary arterial hypertension

刘思言 1崔狄宇 2陈运清1
扫码查看

作者信息

  • 1. 重庆医科大学附属第二医院心内科,重庆 400010
  • 2. 陆军军医大学第一附属医院心内科,重庆 400038
  • 折叠

摘要

肺动脉高压(PAH)是一种严重危害人类健康的肺血管病变,最终会引起肺血管重建和右心室功能障碍.目前,PAH的致病机制尚未阐明.PAH病理生理是复杂和可变的,一氧化氮、前列环素及神经体液和激素通路等各种信号通路之间复杂交错,线粒体相关代谢环境失调及环境和炎症损伤等都参与其中.该文对PAH的病理机制研究进展进行了综述.

Abstract

Pulmonary arterial hypertension(PAH)is a serious pulmonary vascular disease that poses a threat to human health,ultimately leading to pulmonary vascular remodeling and right ventricular dysfunc-tion.At present,the pathogenic mechanism of PAH has not been elucidated.The pathophysiology of PAH is complex and variable,with complex intersections between various signaling pathways such as nitric oxide,prostacyclin,and neurohumoral and hormonal pathways.Mitochondrial related metabolic dysregulation,envi-ronmental and inflammatory damage are also involved.The article reviews the research progress on the patho-logical mechanism of PAH.

关键词

肺动脉高压/病理机制/研究进展

Key words

Pulmonary arterial hypertension/Pathological mechanisms/Research progress

引用本文复制引用

基金项目

国家自然科学基金面上项目(82270490)

出版年

2024
现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
参考文献量40
段落导航相关论文